This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (57)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert H. Lund, MD; Mark W. Moritz, MD

Arch Surg. 1982;117(7):924-928.

Abstract
• The records of 49 consecutive patients treated with Denver peritoneovenous shunts were reviewed to determine the incidence of complications and length of patient survival. Thirty-eight complications (16 types) were identified in 22 (45%) of the patients and, in 10 instances, contributed to subsequent death. Ten percent of shunts failed during long-term follow-up. The 54% one-year survival by life-table analysis of patients with cirrhosis treated with the Denver shunt matched results previously reported for similar patients treated with the LeVeen shunt. Patients with intra-abdominal malignant neoplasms had an 11% one-year survival overall. Although it too is associated with significant complications, the Denver peritoneovenous shunt seems to have a lower failure rate and a lower incidence of complications than the LeVeen peritoneovenous shunt. Thus, the Denver shunt offers advantages in the treatment of intractable ascites.

(Arch Surg 1982;117:924-928)

Author Affiliations
From the Department of Surgery, Washington University School of Medicine, St Louis.

Footnotes
Accepted for publication Sept 24, 1981.

Reprint requests to Department of Surgery, Washington University School of Medicine, 4960 Audubon Ave, St Louis, MO 63110 (Dr Lund).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Solid intracardiac mass complicating peritoneovenous shunting
Jurmann et al.
ICVTS 2006;5:660-661.
ABSTRACT | FULL TEXT  

Peritoneovenous shunting is an effective treatment for intractable ascites
Sooriakumaran et al.
Postgrad. Med. J. 2005;81:259-261.
ABSTRACT | FULL TEXT  

Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter
Iyengar and Herzog
AM J HOSP PALLIAT CARE 2002;19:35-38.
ABSTRACT  

LeVeen vs Denver Peritoneovenous Shunts for Intractable Ascites of Cirrhosis: A Randomized, Prospective Trial
Fulenwider et al.
Arch Surg 1986;121:351-355.
ABSTRACT  

Peritoneovenous Shunts: Lessons Learned From an Eight-Year Experience With 70 Patients
Fulenwider et al.
Arch Surg 1984;119:1133-1137.
ABSTRACT  

Central Venous Thrombosis and Embolism Associated With Peritoneovenous Shunts
Foley et al.
Arch Surg 1984;119:713-720.
ABSTRACT